Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B-Reference-Cited by-同舟云学术

Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B

Published:2021-08 Issue: Volume:Volume 14 Page:4967-4976
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Liao Guichan,Ding Xia,Xia Muye,Wu Yin,Chen Hongjie,Fan Rong,Zhang Xiaoyong,Cai Shaohang^ORCID,Peng Jie

Publisher

Informa UK Limited

Subject

General Medicine

Reference32 articles.

1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

2. AASLD guidelines for treatment of chronic hepatitis B

3. Improvements in the management of chronic hepatitis B virus infection

4. Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B

5. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy;Liver International;2024-07-15

2. Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits;Infectious Diseases and Clinical Microbiology;2024-06-28

3. Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm;Clinical and Molecular Hepatology;2023-10-01

4. Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes;Clinical Infectious Diseases;2023-08-26

5. Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies;JHEP Reports;2023-06